Literature DB >> 26215052

Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?

Avraham Beigelman1, Leonard B Bacharier2, Jack Baty3, Richard Buller2, Sheila Mason2, Kenneth B Schechtman3, Geneline Sajol4, Megan Isaacson-Schmid2, Mario Castro4, Gregory A Storch2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26215052      PMCID： PMC4600448          DOI： 10.1016/j.jaci.2015.06.011

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

2.  Determinants of asthma after severe respiratory syncytial virus bronchiolitis.

Authors:  Leonard B Bacharier; Rebecca Cohen; Toni Schweiger; Huiquing Yin-Declue; Chandrika Christie; Jie Zheng; Kenneth B Schechtman; Robert C Strunk; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2012-03-22       Impact factor: 10.793

3.  Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.

Authors:  Avraham Beigelman; Megan Isaacson-Schmid; Geneline Sajol; Jack Baty; Oscar M Rodriguez; Erin Leege; Kevin Lyons; Toni L Schweiger; Jie Zheng; Kenneth B Schechtman; Mario Castro; Leonard B Bacharier
Journal:  J Allergy Clin Immunol       Date:  2014-11-18       Impact factor: 10.793

4.  Azithromycin induces anti-viral responses in bronchial epithelial cells.

Authors:  V Gielen; S L Johnston; M R Edwards
Journal:  Eur Respir J       Date:  2010-02-11       Impact factor: 16.671

Review 5.  The role of early life viral bronchiolitis in the inception of asthma.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-04

6.  Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.

Authors:  Ann R Falsey; Maria A Formica; John J Treanor; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells.

Authors:  Masanori Asada; Motoki Yoshida; Tomoko Suzuki; Yukimasa Hatachi; Takahiko Sasaki; Hiroyasu Yasuda; Katsutoshi Nakayama; Hidekazu Nishimura; Ryoichi Nagatomi; Hiroshi Kubo; Mutsuo Yamaya
Journal:  Antiviral Res       Date:  2009-05-20       Impact factor: 5.970

8.  Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells.

Authors:  Aline Schögler; Brigitte S Kopf; Michael R Edwards; Sebastian L Johnston; Carmen Casaulta; Elisabeth Kieninger; Andreas Jung; Alexander Moeller; Thomas Geiser; Nicolas Regamey; Marco P Alves
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

9.  Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community.

Authors:  M L Houben; F E J Coenjaerts; J W A Rossen; M E Belderbos; R W Hofland; J L L Kimpen; L Bont
Journal:  J Med Virol       Date:  2010-07       Impact factor: 2.327

10.  Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy.

Authors:  Gabriel J Escobar; Anthony S Masaquel; Sherian X Li; Eileen M Walsh; Patricia Kipnis
Journal:  BMC Pediatr       Date:  2013-06-19       Impact factor: 2.125
  10 in total
  4 in total

Review 1.  Early-life respiratory infections and asthma development: role in disease pathogenesis and potential targets for disease prevention.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-04

2.  Effects of Macrolide Treatment during the Hospitalization of Children with Childhood Wheezing Disease: A Systematic Review and Meta-Analysis.

Authors:  Chien-Yu Lin; Tzu-Lin Yeh; Shu-Jung Liu; Hsin-Hui Lin; Yu-Jyun Cheng; Hua-His Hung; Mu-Chieh Tsai; Jui-Ming Liu; Wei-Te Lei
Journal:  J Clin Med       Date:  2018-11-09       Impact factor: 4.241

3.  The effects of macrolides in children with reactive airway disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Te Lei; Hsin Hui Lin; Mu-Chieh Tsai; Hua-His Hung; Yu-Jyun Cheng; Shu-Jung Liu; Chien Yu Lin; Tzu-Lin Yeh
Journal:  Drug Des Devel Ther       Date:  2018-11-08       Impact factor: 4.162

4.  Macrolides in critically ill patients with Middle East Respiratory Syndrome.

Authors:  Yaseen M Arabi; Ahmad M Deeb; Fahad Al-Hameed; Yasser Mandourah; Ghaleb A Almekhlafi; Anees A Sindi; Awad Al-Omari; Sarah Shalhoub; Ahmed Mady; Basem Alraddadi; Abdullah Almotairi; Kasim Al Khatib; Ahmed Abdulmomen; Ismael Qushmaq; Othman Solaiman; Abdulsalam M Al-Aithan; Rajaa Al-Raddadi; Ahmad Ragab; Abdulrahman Al Harthy; Ayman Kharaba; Jesna Jose; Tarek Dabbagh; Robert A Fowler; Hanan H Balkhy; Laura Merson; Frederick G Hayden
Journal:  Int J Infect Dis       Date:  2019-01-25       Impact factor: 3.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.